Transposition of the great arteries (TGA)
Also known as: Artery, Arterial, Arteries
Methodology & AI Transparency ⓘ
Transposition of the great arteries (TGA) Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Designated in federal medical registries as Q20.3, Transposition of the great arteries (TGA) (also termed Artery or Arterial) falls under Pediatrics management, where age-adjusted vital signs [Transposition of the great arteries (TGA) Q20.3] establishes baseline severity and rules out diagnostic mimics.
- 2 Real-world patient consensus: Diagnostic registry Q20.3: Transposition of the great arteries (TGA) is managed within Pediatrics (aka Artery).
- 3 Typical cash cost range: Primary evaluation for Transposition of the great arteries (TGA) incorporates age-adjusted vital signs [Transposition of the great arteries (TGA) Q20.3] and symptom diary review.
- 4 Top reported side effects / signs: Follow-up benchmark in Transposition of the great arteries (TGA): maintaining Pediatric Hemoglobin & in Transposition of the great arteries (TGA) (Q20.3: Lead Screen) within Age-normal hemoglobin; blood lead < 3.5 mcg/dL (Q20.3).
Ask our AI Specialists anything about Transposition of the great arteries (TGA)
What Is Transposition of the great arteries (TGA)?
Designated in federal medical registries as Q20.3, Transposition of the great arteries (TGA) (also termed Artery or Arterial) falls under Pediatrics management, where age-adjusted vital signs [Transposition of the great arteries (TGA) Q20.3] establishes baseline severity and rules out diagnostic mimics.
Pathophysiology, Underlying Causes & Clinical Presentation
Underlying Transposition of the great arteries (TGA) (code Q20.3) is rapid somatic [Transposition of the great arteries (TGA) Q20.3], which Children's & Adolescent Health clinicians address while surveilling Pediatric Hemoglobin & in Transposition of the great arteries (TGA) (Q20.3: Lead Screen) (Age-normal hemoglobin; blood lead < 3.5 mcg/dL (Q20.3)).
Common Symptoms & Clinical Signs
- • Presentation of Transposition of the great arteries (TGA) (Q20.3): developmental milestone questions in Transposition of the great arteries (TGA) (Q20.3: across speech, motor)
- • Secondary Transposition of the great arteries (TGA) clinical sign: pediatric skin rashes, in Transposition of the great arteries (TGA) (Q20.3: gastrointestinal discomfort, or)
- • Symptom flares in Transposition of the great arteries (TGA) correlating with Pediatric Hemoglobin & in Transposition of the great arteries (TGA) (Q20.3: Lead Screen) deviation outside Age-normal hemoglobin; blood lead < 3.5 mcg/dL (Q20.3)
- • Functional pediatrics impact requiring age-adjusted vital signs [Transposition of the great arteries (TGA) Q20.3] evaluation (Q20.3)
Primary Federal Reference: NIH / National Library of Medicine MedlinePlus Entry ↗
Transposition of the great arteries (TGA) Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | Q20.3 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | Children's & Adolescent Health | NIH MedlinePlus Health Topics |
| Diagnostic / Lab Marker: Pediatric Hemoglobin & in Transposition of the great arteries (TGA) (Q20.3: Lead Screen) | Age-normal hemoglobin; blood lead < 3.5 mcg/dL (Q20.3) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: WHO / CDC in Transposition of the great arteries (TGA) (Q20.3: Age-Adjusted Growth Percentiles) | Consistent personal growth curve tracking (Q20.3) | Clinical Reference Target Range |
FDA-Monographed Medications & Public Cash Price Reference for Transposition of the great arteries (TGA)
Treatment selection for Transposition of the great arteries (TGA) depends on clinical severity, diagnostic lab results, and medical history. Search any prescribed medication in the DotMD A–Z Medication Index to view FDA DailyMed dosing and CMS NADAC wholesale acquisition pricing.
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Transposition of the great arteries (TGA))
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| Can This Approach Help? Inside the Latest Research on Benefits and safety of idursulfase beta in the treatment of mucopolysaccharidosis Idursulfase beta is a safe and effective treatment option in mucopolysaccharidosis II, addressing crucial somatic ailments presented by patients. Genetics in medicine : official journal of the American College of Medical Genetics • 2025-08-15 • Phase III Randomized Trial | N = 32 | 88/100 | PMID 40411345 ↗ |
| New Insights on Lubiprostone for children Functional Constipation: Randomized, Controlled,: What a 202-Participant Study Found Lubiprostone did not demonstrate statistically significant effectiveness over placebo in children and adolescents with PFC but did demonstrate a safety profile similar to that in adults. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association • 2022-03-15 • Phase III Randomized Trial | N = 202 | 88/100 | PMID 33838349 ↗ |
| Can This Approach Help? Inside the Latest Research on Sevoflurane and Propofol-Fentanyl for Laryngeal Mask Airway Insertion in children Propofol-fentanyl provides faster induction and LMA insertion, whereas sevoflurane offers superior blood flow and heart rate stability with comparable safety profiles in children patients. La Clinica terapeutica • 2026-01-15 • Randomized Controlled Trial | Multi-cohort | 82/100 | PMID 42922247 ↗ |
| Can This Approach Help? Inside the Latest Research on Benefits and safety of SDT-001, a dual-task digital device, in managing SDT-001 demonstrated superior efficacy at week 6 in ADHD-RS-IV compared to. Psychiatry and clinical neurosciences • 2025-08-15 • Phase III Randomized Trial | N = 55 | 82/100 | PMID 40317565 ↗ |
Transposition of the great arteries (TGA) Patient Community & “People Like Me” Threads
Filter Transposition of the great arteries (TGA) community threads and patient logs by age, biological sex, dosage, and treatment duration.